Back to Agenda
Regulatory Affairs: Part 3: Special Topics and Adverse Event Reporting in Clinical Research
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
Kevin Daniel Healy, PhD
Senior Vice President Regulatory Affairs
Entrada Therapeutics, United States
Regulatory Affairs: Part 3: Special Topics and Adverse Event Reporting in Clinical Research
Have an account?